Literature DB >> 1497003

Impact and cost-effectiveness of smoking interventions.

J Tsevat1.   

Abstract

Cigarette smoking is the foremost preventable cause of death in the United States. Along with being a major contributor to lung cancer, chronic obstructive pulmonary disease, and cerebrovascular disease, smoking is one of several modifiable risk factors for coronary artery disease (CAD). The Coronary Heart Disease Policy Model is a computer simulation model of CAD in the United States. Using the model, one can project CAD incidence, prevalence, events, mortality, cost, cost-effectiveness, and gains in life expectancy from various risk factor modifications, including smoking interventions. The model projects that reducing the number of cigarettes smoked by 50% would increase the population-wide life expectancy of 35-year-old U.S. citizens by 0.4 year. Eliminating smoking would yield population-wide gains of 0.8 year for 35-year-old males and 0.7 year for 35-year-old females. These gains are comparable to those achieved with strict control of cholesterol levels, diastolic blood pressure, or weight. Gains for the smokers themselves would be much greater. On average, 35-year-old male smokers would live 1.2 years longer if they reduced the number of cigarettes smoked by 50%, and 2.3 years longer if they quit smoking. Females 35 years of age would live 1.5 years longer by cutting back by 50% and 2.8 years longer by quitting. These gains are equal to or greater than gains that individuals would realize by reducing serum cholesterol levels of 240-299 mg/dL to 200 mg/dL; controlling mild hypertension; or reducing weight from greater than or equal to 130% ideal body weight to ideal body weight. Gains projected by the Coronary Heart Disease Policy Model are comparable to those forecast by others, who have projected that young adults would gain approximately 0.2-8.7 years by quitting smoking, depending on their smoking history. Two studies have examined the cost-effectiveness of smoking interventions. One found that counseling smokers to quit would cost only $705-988 per year of life saved for males and $1,204-2,058 per year of life saved for females. The second study found that prescribing nicotine gum as an adjunct to counseling would cost only $4,113-6,465 per year of life saved for males and $6,880-9,473 per year of life saved for females. These cost-effectiveness ratios are more favorable than those of most other current healthcare interventions. Smoking cessation would increase population-wide life expectancy by about a year and the life expectancy of a smoker by several years.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1497003     DOI: 10.1016/0002-9343(92)90627-n

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial.

Authors:  R D Reid; A Pipe; W A Dafoe
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Smoking cessation and the nicotine patch: much more to be done.

Authors:  S E Kimmel; N Benowitz
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

3.  Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.

Authors:  Harold S Javitz; Susan M Zbikowski; Mona Deprey; Timothy A McAfee; Jennifer B McClure; Julie Richards; Sheryl L Catz; Lisa M Jack; Gary E Swan
Journal:  Transl Behav Med       Date:  2011-03-01       Impact factor: 3.046

Review 4.  Economic implications of smoking cessation therapies: a review of economic appraisals.

Authors:  D R Cohen; G H Fowler
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 5.  Cost effectiveness of coronary heart disease prevention strategies in adults.

Authors:  A D Brown; A M Garber
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 6.  Benefits of stopping smoking.

Authors:  E Frank
Journal:  West J Med       Date:  1993-07

Review 7.  The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Authors:  Victor U Ekpu; Abraham K Brown
Journal:  Tob Use Insights       Date:  2015-07-14

8.  The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations.

Authors:  David H Au; Christopher L Bryson; Jason W Chien; Haili Sun; Edmunds M Udris; Laura E Evans; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2009-02-05       Impact factor: 5.128

9.  Risk factors of atherosclerosis in male smokers, passive smokers, and hypertensive nonsmokers in central Iran.

Authors:  Rezvan Ansari; Alireza Khosravi; Ahmad Bahonar; Shahin Shirani; Roya Kelishadi; Zahra Khosravi
Journal:  ARYA Atheroscler       Date:  2012

10.  Addressing tobacco in managed care: results of the 2002 survey.

Authors:  Carol McPhillips-Tangum; Carmella Bocchino; Rita Carreon; Caroline Erceg; Bob Rehm
Journal:  Prev Chronic Dis       Date:  2004-09-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.